Abstract

V icharchika is explained as one a mong Ekadasha Kshudra Kustha. The clinical f eatures of vicharchika like Kandu, Pidaka, Shyavavar nata, S rava, Rookshata, Daha, Raji, and Ve dana are very much similar with the features of Eczema. This is an inflammatory response produced by various internal and external factors. To manage such inflammatory condition of the skin, shamana chikitsa, in th e form of bahya and abhyantara sneha prayoga was planned in order to have a safe and effective result in treating Vicharchika vis - a - vis Eczema. The objective of this study was , to evaluate the efficacy of Amritadi Ghrita as Shamana sneha along with the ext ernal application of Kutaja Soorya paka Taila in the management of Vicharchika vis - a - vis Eczema . It is an observational clinical study with pre, mid and post test design where 30 patients of Vicharchika vis - a - vis Eczema were randomly selected and subjected to deepana and pachana with Trikatu choo r na administered in a do se of 2 g thrice daily before food with ushnodaka , until nirama lakshanas were observed. Shamana snehapana by Amritadi Ghritha was advised in the dose of 30 ml , in empty stom ac h at annakala f or 30 days along with external application of Kutajasooryapaka Taila twice a day after thoroughly cleaning the affe cted area of the skin with luke warm water. Pathya ahara and Vihara were advised throughout the course of the study. In the present study , res ults obtained with respect to all the

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.